María Torrejón Victoria
Access & HTA Lead at UCB Iberia- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
-
English Full professional proficiency
-
German Professional working proficiency
-
Valencian Full professional proficiency
-
Spanish Native or bilingual proficiency
Topline Score
Bio
Experience
-
UCB Iberia
-
Spain
-
Pharmaceutical Manufacturing
-
1 - 100 Employee
-
Access & HTA Lead
-
Mar 2023 - Present
-
-
-
OMAKASE CONSULTING
-
Spain
-
Business Consulting and Services
-
1 - 100 Employee
-
Senior Consultant - Health Economics & Market Access
-
Sep 2021 - Mar 2023
Health Economics & Market Access Senior Consultant - Evidence generation Consultant Health Economics & Market Access Senior Consultant - Evidence generation Consultant
-
-
-
Farma Leaders Talento
-
Spain
-
Pharmaceutical Manufacturing
-
1 - 100 Employee
-
Miembro
-
May 2020 - Feb 2023
-
-
-
World Health Management (WHM)
-
Spain
-
Wellness and Fitness Services
-
1 - 100 Employee
-
-
Aug 2019 - Sep 2021
-
-
-
Dec 2017 - Aug 2019
Working on projects related to the pharma industry, specifically in the area of Market Access and Institutional Affairs. Including:- P&R value proposition- Market Access related technical reports- Stakeholder mapping- Plan and follow-up drugs and Medical Devices MA projects- Stakeholder Engagement Plans - Creating proposals adapted to the needs of every client
-
-
-
Oct 2016 - Nov 2017
-
-
-
-
Pharmacist
-
Aug 2014 - Sep 2016
Pharmacist in the Program of Multidisciplinary Commissions of Therapeutic Consensus in Dirección General de Farmacia y Productos Sanitarios - Conselleria de Sanitat Universal i Salut Pública. During my time in DGFyPS I managed the Hepatitis C Antivirals, Hemato-Oncologic Drugs, as well as Autoimmune Disease Committees. Throughout my time there, I was able to develop relationships with KOLs and other stakeholders as regional payers. Pharmacist in the Program of Multidisciplinary Commissions of Therapeutic Consensus in Dirección General de Farmacia y Productos Sanitarios - Conselleria de Sanitat Universal i Salut Pública. During my time in DGFyPS I managed the Hepatitis C Antivirals, Hemato-Oncologic Drugs, as well as Autoimmune Disease Committees. Throughout my time there, I was able to develop relationships with KOLs and other stakeholders as regional payers.
-
-
-
Hospital Clínico Universitario de Valencia
-
Spain
-
Hospitals and Health Care
-
200 - 300 Employee
-
Practicum Student
-
Oct 2012 - Mar 2013
Student in the pharmacy unit of the Hospital Clínico Universitario of Valencia. In my training period I worked in the different sections of the pharmacy service and I became specialized in the section of management of clinical trials (medication preparation, patients' randomization, dispensation of clinical trials medication, stock management, data registry in CRD, CT Protocols Data Base Management) Student in the pharmacy unit of the Hospital Clínico Universitario of Valencia. In my training period I worked in the different sections of the pharmacy service and I became specialized in the section of management of clinical trials (medication preparation, patients' randomization, dispensation of clinical trials medication, stock management, data registry in CRD, CT Protocols Data Base Management)
-
-
Education
-
Universidad Carlos III de Madrid
Specialization Course in Economic Evaluation of Medicines, Pharmacoeconomics -
Universidad de Alcalá
Pharmacoepidemiology and pharmacovigilance master degree, pharmacoepidemiology & pharmacovigilance -
CESIF
Course of Professional Expert in Registration of Medicines and Regulatory Affairs, Regulatory Affairs -
Harvard University
Prescription Drug Regulation, Cost, and Access: Current Controversies in Context, Market Access -
Escuela Valenciana de Estudios para la Salud (EVES)
Public Health diploma -
Universitat de València
Master of Education - MEd, Secondary education teacher -
Westfälische Wilhelms-Universität Münster
Bachelor of Pharmacy - BPharm, ERASMUS 12 months -
Universitat de València
Bachelor of Pharmacy - BPharm